Skip to main content
SpringerLink
Log in

Infections fongiques sévères en réanimation

  • Chapter
Infectiologie en réanimation

Part of the book series: Références en réanimation. Collection de la SRLF ((SRLF))

  • 1033 Accesses

Résumé

En réanimation les infections fongiques sont fréquentes et représentent la troisième cause de sepsis documentés derrière les infections à staphylocoques et à streptocoques ou Pseudomonas aeruginosa selon les études, soit environ 18 % des sepsis documentés [1, 2]. Ces infections sont dominées par les infections à Candida, parmi lesquelles trois types de pathologie sont observés : les candidémies, les candidoses profondes et les péritonites à Candida chez les patients de réanimation chirurgicale. Les infections à Candida sont fréquemment associées aux soins notamment en ce qui concernent les infections de cathéters et les candidémies [3]. De nombreux facteurs de risque de candidose invasive ont été identifiés et sont souvent multiples chez les patients de réanimation, ce qui en fait un sous-groupe de patients à haut risque.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Vincent J-L, Sakr Y, Sprung C, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344–53

    Article  PubMed  Google Scholar 

  2. Vincent J-L, Rello J, Marshall J, et al. (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323–9

    Article  PubMed  CAS  Google Scholar 

  3. Ostrosky-Zeichner L, Pappas PG (2006) Invasive candidiasis in the intensive care unit. Crit Care Med 34: 857–63

    Article  PubMed  Google Scholar 

  4. Burghi G, Lemiale V Seguin A, et al. (2011) Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med 37: 1605–12

    Article  PubMed  Google Scholar 

  5. Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3: 685–702

    Article  PubMed  Google Scholar 

  6. Leroy O, Gangneux JP, Montravers P, et al. (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37: 1612–8

    Article  PubMed  Google Scholar 

  7. Bougnoux ME, Kac G, Aegerter P, et al. (2008) Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34: 292–9

    Article  PubMed  Google Scholar 

  8. Montravers P, Mira JP, Gangneux JP, et al. (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 17: 1061–7

    Article  PubMed  CAS  Google Scholar 

  9. Viscoli C, Girmenia C, Marinus A, et al. (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28: 1071–9

    Article  PubMed  CAS  Google Scholar 

  10. Horn DL, Neofytos D, Anaissie EJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48: 1695–703

    Article  PubMed  CAS  Google Scholar 

  11. Slavin MA, Sorrell TC, Marriott D, et al. (2010) Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 65: 1042–51

    Article  PubMed  CAS  Google Scholar 

  12. Playford EG, Marriott D, Nguyen Q, et al. (2008) Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 36: 2034–9

    Article  PubMed  Google Scholar 

  13. Lortholary O, Desnos-Ollivier M, Sitbon K, et al. (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55: 532–8

    Article  PubMed  CAS  Google Scholar 

  14. Sandven P, Bevanger L, Digranes A, et al. (2006) Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 44: 1977–81

    Article  PubMed  Google Scholar 

  15. Eggimann P, Bille J, Marchetti O (2011) Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 1: 37

    Article  PubMed  Google Scholar 

  16. Olaechea PM, Palomar M, León-Gil C, et al. (2004) Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 23: 323–30

    Article  PubMed  CAS  Google Scholar 

  17. Pittet D, Monod M, Suter PM, et al. (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–8

    Article  PubMed  CAS  Google Scholar 

  18. León C, Ruiz-Santana S, Saavedra P et al. (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34: 730–7

    Article  PubMed  Google Scholar 

  19. León C, Ruiz-Santana S, Saavedra P, et al. (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in nonneutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37: 1624–33

    Article  PubMed  Google Scholar 

  20. Lau A, Halliday C, Chen SC, et al. (2010) Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 48:811–6

    Article  PubMed  Google Scholar 

  21. McMullan R, Metwally L, Coyle PV, et al. (2008) A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 46: 890–6

    Article  PubMed  CAS  Google Scholar 

  22. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. (2011) β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 52: 750–70

    Article  PubMed  CAS  Google Scholar 

  23. Odabasi Z, Mattiuzzi G, Estey E, et al. (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39: 199–205

    Article  PubMed  CAS  Google Scholar 

  24. Mohr JF, Sims C, Paetznick V, et al. (2011) Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 49: 58–61

    Article  PubMed  Google Scholar 

  25. Posteraro B, De Pascale G, Tumbarello M, et al. (2011) Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index. Crit Care l5: R249

    Article  Google Scholar 

  26. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49: 3640–5

    Article  PubMed  CAS  Google Scholar 

  27. Parkins MD, Sabuda DM, Elsayed S, Laupland KB (2007) Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J. Antimicrob. Chemother 60: 613–8

    Article  PubMed  CAS  Google Scholar 

  28. Pappas PG, Kauffman CA, Andes D, et al. (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48: 503–35

    Article  PubMed  CAS  Google Scholar 

  29. Mora-Duarte J, Betts R, Rotstein C, et al. (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347: 2020–9

    Article  PubMed  CAS  Google Scholar 

  30. Reboli AC, Rotstein C, Pappas PG, et al. (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356: 2472–82

    Article  PubMed  CAS  Google Scholar 

  31. Reboli AC, Shorr AF, Rotstein C, et al. (2011) Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis 11: 261

    Article  PubMed  CAS  Google Scholar 

  32. Liu CY, Huang LJ, Wang WS, et al. (2009) Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome. J Infect 58: 154–60

    Article  PubMed  CAS  Google Scholar 

  33. Nucci M, Anaissie E, Betts RF, et al. (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51: 295–303

    Article  PubMed  Google Scholar 

  34. Kuhn DM, George T, Chandra J, et al. (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 1773–80

    Article  PubMed  CAS  Google Scholar 

  35. Dupont H, Bourichon A, Paugam-Burtz C, et al. (2003) Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31: 52–7

    Article  Google Scholar 

  36. Dupont H, Paugam-Burtz C, Muller-Serieys C, et al. (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137: 1341–1346

    Article  PubMed  Google Scholar 

  37. Azoulay E, Dupont H, Tabah A, et al. (2012) Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 40: 813–22

    Article  PubMed  CAS  Google Scholar 

  38. Eggimann P, Francioli P, Bille J, et al. (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27: 1066–72

    Article  PubMed  CAS  Google Scholar 

  39. Meersseman W, Lagrou K, Maertens J, Wijngaerden EV (2007) Invasive Aspergillosis in the Intensive Care Unit. Clin Infect Dis 45(2): 205–16

    Article  PubMed  Google Scholar 

  40. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. (2005) Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 9: R191–9

    Article  PubMed  Google Scholar 

  41. Meersseman W, Lagrou K, Maertens J, et al. (2008) Galactomannan in Bronchoalveolar Lavage Fluid A Tool for Diagnosing Aspergillosis in Intensive Care Unit Patients. Am J Respir Crit Care Med 177: 27–34

    Article  PubMed  Google Scholar 

  42. Pagano L, Akova M, Dimopoulos G, et al. (2011) Assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 66: i5–l4

    Article  PubMed  CAS  Google Scholar 

  43. Kontoyiannis DP, Marr KA, Park BJ, et al. (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50: 1091–100

    Article  PubMed  Google Scholar 

  44. Pappas PG, Alexander BD, Andes DR, et al. (2010) Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50: 1101–11

    Article  PubMed  Google Scholar 

  45. Worth LJ, Slavin MA (2009) Bloodstream infections in haematology: risks and new challenges for prevention. Blood Rev 3: 113–22

    Article  Google Scholar 

  46. Sipsas NV, Lewis RE, Tarrand J, et al. (2009) Candidemia in patients with hématologic malignancies in the era of new antifungal agents (2001–2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115: 4745–52

    Article  PubMed  CAS  Google Scholar 

  47. Cordonnier C, Pautas C, Maury S, et al. (2009) Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis 48: 1042–51

    Article  PubMed  CAS  Google Scholar 

  48. Pagano L, Caira M, Nosari A, et al. (2011) The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica 96: 1366–70

    Article  PubMed  Google Scholar 

  49. De Castro N, Mazoyer E, Porcher R, et al. (2012) Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000–2007. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 18: E185–7

    Article  Google Scholar 

  50. Albano L, Bretagne S, Mamzer-Bruneel MF, et al. (2009) Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis 48: 194–202

    Article  PubMed  Google Scholar 

  51. Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O (2007) Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4: e21

    Article  PubMed  Google Scholar 

  52. Lortholary O, Nunez H, Brauner MW, Dromer F (2004) Pulmonary cryptococcosis. Semin Respir Crit Care Med 25: 145–57

    Article  PubMed  Google Scholar 

  53. Marchetti O, Lamoth F, Mikulska M, et al. (2011) ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant Available from: http://www.ncbi.nlm.nih.gov/pubmed/21927034/pubmed/21927034

  54. Perfect JR, Dismukes WE, Dromer F, et al. (2010) Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 50: 291–322

    Article  PubMed  Google Scholar 

  55. Haddow LJ, Colebunders R, Meintjes G, et al. (2010) Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 10: 791–802

    Article  PubMed  Google Scholar 

  56. Segal BH (2009) Aspergillosis. N Engl J Med 360: 1870–84

    Article  PubMed  CAS  Google Scholar 

  57. Lortholary O, GangneuxJP, Sitbon K, et al. (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007). Clin Microbiol Infect 17: 1882–9

    Article  PubMed  CAS  Google Scholar 

  58. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP (2011) The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 52: 1144–55

    Article  PubMed  Google Scholar 

  59. Bergeron A, Porcher R, Sulahian A, et al. (2012) The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hématologic malignancies. Blood 119: 1831–7

    Article  PubMed  CAS  Google Scholar 

  60. Caillot D, Latrabe V, Thiébaut A, et al. (2010) Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: a useful tool for diagnosis and assessment of outcome in clinical trials. Eur J Radiol 74: el72–5

    Article  Google Scholar 

  61. Bergeron A, Belle A, Sulahian A, et al. (2010) Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hématologic malignancies. Chest 137: 410–5

    Article  PubMed  Google Scholar 

  62. Herbrecht R, Denning DW, Patterson TF, et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408–15

    Article  PubMed  CAS  Google Scholar 

  63. Nivoix Y, Veiten M, Letscher-Bru V, et al. (2008) Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47: 1176–84

    Article  PubMed  Google Scholar 

  64. Baddley JW, Andes DR, Marr K, et al. (2010) Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect 50: 1559–67

    Article  Google Scholar 

  65. Petrikkos G, SkiadaA, Lortholary O, et al. (2012) Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases 54: S23–34

    Article  PubMed  Google Scholar 

  66. Lanternier F, Dannaoui E, Morizot G, et al. (2012) A Global analysis of mucormycosis in France: The RetroZygo Study (2005–2007). Clinical Infectious Diseases 54: S35–43

    Article  PubMed  CAS  Google Scholar 

  67. Rammaert B, Lanternier F, Zahar JR, et al. (2012) Healthcare-Associated Mucormycosis. Clinical Infectious Diseases 54: S44–54

    Article  PubMed  Google Scholar 

  68. Wahba H, Truong MT, Lei X, et al. (2008) Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis 46: 1733–7

    Article  PubMed  Google Scholar 

  69. Pagano L, Valentini CG, Caira M, Fianchi L (2009) Zygomycosis: current approaches to management of patients with haematological malignancies. Br J Haematol 146: 597–606

    Article  PubMed  CAS  Google Scholar 

  70. Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20: 695–704

    Article  PubMed  CAS  Google Scholar 

  71. Lortholary O, Obenga G, Biswas P, et al. (2010) International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54: 4446–50

    Article  PubMed  CAS  Google Scholar 

  72. Cortez KJ, Roilides E, Quiroz-Telles F, et al. (2008) Infections caused by Scedosporium spp. Clin. Microbiol. Rev 21: 157–97

    Article  PubMed  CAS  Google Scholar 

  73. Troke P, Aguirrebengoa K, Arteaga C, et al. (2008) Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 52: 1743–50

    Article  PubMed  CAS  Google Scholar 

  74. Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350: 2487–98

    Article  PubMed  CAS  Google Scholar 

  75. Catherinot E, Lanternier F, Bougnoux M, et al. (2010) Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am 24: 107–38

    Article  PubMed  Google Scholar 

  76. Canet E, Osman D, Lambert J, et al. (2011) Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care 15: R91

    Article  PubMed  Google Scholar 

  77. Barbier F, Coquet I, Legriel S, et al. (2009) Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 35: 1678–86

    Article  PubMed  Google Scholar 

  78. Mofenson LM, Brady MT, Danner SP, et al. (2009) Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pédiatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 58: 1–166

    PubMed  Google Scholar 

  79. Helweg-Larsen J, BenGeld T, Atzori C, Miller RF (2009) Clinical efficacy of first-and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tricentre cohort study. J Antimicrob Chemother 64: 1282–90

    Article  PubMed  CAS  Google Scholar 

  80. Bozzette SA, Sattler FR, Chiu J, et al. (1990) A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 323: 1451–7

    Article  PubMed  CAS  Google Scholar 

  81. Moon SM, Kim T, Sung H, et al. (2011) Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients. Antimicrob Agents Chemother 55: 4613–8

    Article  PubMed  CAS  Google Scholar 

  82. Cortez KJ, Roilides E, Quiroz-Telles F, et al. (2008) Infections caused by Scedosporium spp. Clin. Microbiol. Rev 21: 157–97

    Article  PubMed  CAS  Google Scholar 

  83. Moore EC, Padiglione AA, Wasiak J, et al. (2010) Candida in burns: risk factors and outcomes. J Burn Care Res 31: 257–63

    Article  PubMed  Google Scholar 

  84. Wheat LJ, Freifeld AG, Kleiman MB, et al. (2007) Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45: 807–25

    Article  PubMed  Google Scholar 

  85. Galgiani JN, Ampel NM, Blair JE, et al. (2005) Coccidioidomycosis. Clin Infect Dis 41: 1217–23

    Article  PubMed  Google Scholar 

  86. Chapman SW, Dismukes WE, Proia LA, et al. (2008) Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 46: 1801–12

    Article  PubMed  CAS  Google Scholar 

  87. Kauffman CA (2007) Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115–32

    Article  PubMed  CAS  Google Scholar 

  88. Rosenstein NE, Emery KW, Werner SB, et al. (2001) Risk Factors for Severe Pulmonary and Disseminated Coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 32: 708–14

    Article  PubMed  CAS  Google Scholar 

  89. Smith JA, Kauffman CA (2010) Blastomycosis. Proc Am Thorac Soc 7: 173–80

    Article  PubMed  Google Scholar 

  90. Ustianowski AP, Sieu TPM, Day JN (2008) Pénicillium marneffei infection in HIV Curr Opin Infect Dis 21:31–6

    Article  Google Scholar 

  91. Blyth CC, Chen SCA, Slavin MA, et al. (2009) Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pédiatric patients. Pediatrics 123: 1360–8

    Article  PubMed  Google Scholar 

  92. Benjamin DK Jr, Stoll BJ, Gantz MG, et al. (2010) Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126: e865–73

    Article  PubMed  Google Scholar 

  93. Finco G, Sanna D, Evangelista M, et al. (2011) Fungal infections in pédiatric intensive care units. J Matern Fetal Neonatal Med 24: 21–3

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service des Maladies Infectieuses et Tropicales Hôpital Universitaire Necker-Enfants malades, Université Paris Descartes Centre d’Infectiologie Necker-Pasteur, IHU Imagine, 149, rue de Sèvres, 75743, Paris Cedex 15, France

    N. Lerolle, P. Parize & O. Lortholary

  2. Centre National de Référence Mycoses Invasives et Antifongiques. Unité de Mycologie Moléculaire, CNRS URA3012. Institut Pasteur, 25, rue du Dr Roux, 75724, Paris Cedex 15, France

    O. Lortholary

Authors
  1. N. Lerolle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Parize
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Lortholary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Lortholary .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Lerolle, N., Parize, P., Lortholary, O. (2013). Infections fongiques sévères en réanimation. In: Infectiologie en réanimation. Références en réanimation. Collection de la SRLF. Springer, Paris. https://doi.org/10.1007/978-2-8178-0389-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0389-0_17

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0388-3

  • Online ISBN: 978-2-8178-0389-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation